Medicare Enrolled
Dr. Pankaj Mehta, MD
Critical Care Medicine · Fresno, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mehta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mehta?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mehta
Dr. Pankaj Mehta is a critical care medicine specialist in Fresno, CA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Mehta performed 1,566 Medicare services across 1,236 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mehta received a total of $11,247 from 55 pharmaceutical and/or device companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mehta is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 19% volume in CA
$11,247 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,566
Medicare services
Top 19% in CA for critical care medicine
1,236
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~92 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
313 | $44 | $142 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
249 | $67 | $224 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
178 | $6 | $75 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
154 | $154 | $1,029 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
104 | $89 | $1,302 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
88 | $32 | $237 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
84 | $9 | $77 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
84 | $6 | $89 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
69 | $58 | $276 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
65 | $88 | $390 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $82 | $361 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
49 | $85 | $1,218 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
34 | $7 | $119 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
18 | $91 | $559 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
12 | $129 | $757 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
11 | $61 | $264 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$11,247
Total received (2018-2024)
Avg $1,607/year across 7 years
Top 13% in CA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
698
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,698 (95.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$336 (3.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$212 (1.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$313
2023
$2,161
2022
$1,324
2021
$1,410
2020
$1,681
2019
$2,217
2018
$2,140
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Noah Medical Corporation
$167
Abbott Laboratories
$128
ABBVIE INC.
$18
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,464
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,611
GlaxoSmithKline, LLC.
$1,500
Sunovion Pharmaceuticals Inc.
$662
Grifols USA, LLC
$399
Mylan Specialty L.P.
$342
GENZYME CORPORATION
$307
Harmony Biosciences LLC
$286
Regeneron Healthcare Solutions, Inc.
$251
Nevro Corp.
$243
Bayer Healthcare Pharmaceuticals Inc.
$211
Abbott Laboratories
$209
Merck Sharp & Dohme Corporation
$207
E.R. Squibb & Sons, L.L.C.
$185
United Therapeutics Corporation
$182
Insmed, Inc.
$174
Noah Medical Corporation
$167
Actelion Pharmaceuticals US, Inc.
$154
Bayer HealthCare Pharmaceuticals Inc.
$140
Axsome Therapeutics, Inc.
$135
Jazz Pharmaceuticals Inc.
$89
Astellas Pharma US Inc
$89
Takeda Pharmaceuticals U.S.A., Inc.
$83
Merck Sharp & Dohme LLC
$78
HARMONY BIOSCIENCES LLC
$72
Allergan Inc.
$67
Baxter Healthcare
$64
Allergan, Inc.
$64
Novo Nordisk Inc
$62
JAZZ PHARMACEUTICALS INC.
$60
Amgen Inc.
$54
ABBVIE INC.
$51
Teva Pharmaceuticals USA, Inc.
$46
Janssen Pharmaceuticals, Inc
$46
Boston Scientific Corporation
$43
Philips Electronics North America Corporation
$40
Pulmonx Corporation
$35
Advanced Respiratory, Inc
$34
Olympus America Inc.
$34
Electromed, Inc.
$34
Itamar Medical Inc
$32
Novartis Pharmaceuticals Corporation
$26
Shire North American Group Inc
$22
PORTOLA PHARMACEUTICALS, INC.
$20
Genentech USA, Inc.
$20
CSL Behring
$18
Resmed Corp
$18
Gilead Sciences, Inc.
$18
AbbVie Inc.
$17
Spinal Simplicity, LLC
$15
PFIZER INC.
$15
La Jolla Pharmaceutical Company
$14
Avadel CNS Pharmaceuticals, LLC
$14
Veran Medical Technologies, Inc.
$13
Circassia Pharmaceuticals Inc
$11
Top 3 companies account for 49.6% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · 1.8mm OD · AIRSUPRA · ANORO · ANORO ELLIPTA · ASMANEX · AVYCAZ · Adempas · Always-On Tip Tracked Forceps · Arikayce · Astral · BEVESPI AEROSPHERE · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CHARTIS CATHETER · CINQAIR · CRESEMBA · DUPIXENT · Dymista · ELIQUIS · ETERNA · FASENRA · GALAXY · GIAPREZA · GLASSIA · HA MINUTEMAN G3-R · Hillrom - Life 2000 Ventilation System · Kcentra · LONHALA MAGNAIR · LUMRYZ · Life 2000 Ventilation System · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PROCLAIM · ProAir Digihaler · Proclaim DRG IPG · Prolastin-C Liquid · QVAR · RECARBRIO · REMODULIN · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SUPERION · SYMBICORT · Saxenda · Senza · Serrated Cup · Spin · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The VitalCough System · UPTRAVI · Utibron · VISERA TRACHEAL INTUBATION VIDEOSCOPE · WAKIX · Wakix · WatchPAT · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
24
Per 100K population
2.4
County median income
$71,434
Nearest hospital
COMMUNITY REGIONAL MEDICAL CENTER
1.2 mi
1.2 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mehta is a clinical cardiology specialist, with above-average Medicare volume (top 19% in CA), with low-engagement industry engagement in the top 13% of CA peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mehta experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mehta performed 313 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mehta receive payments from pharmaceutical companies?
Yes. Dr. Mehta received a total of $11,247 from 55 companies across 698 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mehta's costs compare to other critical care medicines in Fresno?
Dr. Mehta's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mehta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Fresno
Browse critical care medicines in Fresno ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in CA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in CA
Which CA critical care medicines receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology